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Abstract
Continuing our previous work in which we showed wide-ranging strain differences in MPTP 
neurotoxicity in male mice among ten BXD recombinant inbred strains, we replicated our work in 
females from nine of the same strains. Mice received a single s.c. injection of 12.5 mg/kg MPTP 
or saline. Forty-eight hours later the striatum was dissected for neurochemical analysis. Striatal 
dopamine (DA) and its metabolites, DOPAC and HVA, striatal serotonin (5-HT) and its 
metabolite, 5-HIAA, were analyzed using HPLC. Tyrosine hydroxylase (TH) and glial fibrillary 
acidic protein (GFAP), an astrocytic protein that increases during the astroglial response to neural 
injury, were measured using ELISA. There were wide genetic variations in the DA, DOPAC, HVA, 
TH and GFAP responses to MPTP. We also performed principal component analysis (PCA) on the 
difference values, saline minus MPTP, for DA, DOPAC, HVA and TH and mapped the dominant 
principal component to a suggestive QTL on chromosome 1 at the same location that we observed 
previously for males. Moreover, there were significant correlations between the sexes for the effect 
of MPTP on DA, HVA, and TH. Our findings suggest that the systems genetic approach as utilized 
here can help researchers understand the role of sex in individual differences. The same approach 
can pave the way to understand and pinpoint the genetic bases for individual differences in 
pathology attributable to toxicants. Such systems genetics approach has broad implications for 
elucidating gene-environment contributions to neurodegenerative diseases.
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1. Introduction
Heavy metals, multiple pesticides and herbicides are considered to be risk factors for human 
health as acute and chronic exposure to them is linked to an increased risk for development 
of neurodegenerative diseases such as Parkinson’s disease (PD) (Hertzman et al., 1990; Liou 
et al., 1997; Landrigan et al., 2005; McCormack et al., 2005; Tanner et al., 2011). The 
picture concerning exposure to pesticides and neurodegenerative diseases however is not 
clear as there are several conflicting reports regarding these agents as increasing risk for 
sporadic Parkinson’s disease (sPD, Elbaz et al., 2009; Gatto et al., 2009; Firestone et al., 
2010). Differential vulnerability to complex neurological disorders, including PD is 
acknowledged to be related at least in part to host susceptibility (i.e., susceptible genotypes 
exposed to environmental risk factors).
There are a number of approaches to assess how the host responds to a toxic insult. One 
involves epidemiological studies in which subpopulations carrying potential susceptible 
genotypes are recruited and examined for response to the toxicant. Identifying such 
individuals is challenging, but possible (Goldman et al., 2012). Another is the use of 
genetically defined animal models that mimic the individual differences observed in humans 
(Taylor et al., 1973). There are several genetic reference populations of animals, especially 
mice. One such genetic reference population or model is recombinant inbred (RI) strains. RI 
mice are derived from two parental inbred strains by first making an F1 generation of the 
parents, and from the F1 population, making F2 and more advanced intercrosses, making 
families and inbreeding by brother-sister matings for 20 generations or more. In this 
particular model the allelic differences between two or more parental lines segregate among 
a large population of independently derived, but related lines of progeny (Peirce et al., 
2004). This approach enables researchers to relate genomic polymorphisms to phenotypic 
variations in normal or pathological states and therefore assess the genetic basis for 
individual differences in phenotypes. Furthermore, using this approach we can assess the 
genetic basis for individual differences and more importantly, gene-environment and gene-
gene interactions underlying these differences. Thus RI strains of rodents constitute an 
invaluable research tool to aid in identifying the underlying causes of major diseases, 
including neurodegenerative diseases. We recently reported large strain differences in the 
dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in 
male BXD RI mice derived from C57BL/6J and DBA/2J parental strains (Jones et al., 2013). 
MPTP is a prototypical pro-neurotoxicant that targets dopaminergic cells of the nigrostriatal 
pathway of the brain and is broadly used in animals to investigate the factors contributing to 
the vulnerability of the nigrostriatal pathway to toxic insult (O’Callaghan et al., 1990).
Others have addressed genetic-based difference in susceptibility to MPTP neurotoxicity by 
evaluating the effects of this agent in different strains of mice, usually males, and have 
nominated candidate genes on chromosomes 1 (Cook et al., 2003), 13 and 15 (Sedelis et al., 
2003). The use of male animals to investigate host susceptibility to MPTP and other 
neurotoxicants, may be too narrowly focused as we see sex differences in many neurological 
disorders. For example the prevalence of PD, a disorder characterized by degeneration of the 
nigrostriatal pathway, is higher in men compared to women. There are experimental studies 
showing the protective effect of estrogen on the nigrostriatal pathway and dopaminergic 
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cells concerning the neurotoxicity of MPTP and methamphetamine in C57BL/6J mice 
(Dluzen et al., 1996; Miller et al., 1998). Such findings suggest that in order to more fully 
elucidate the role of host susceptibility, both sexes should be evaluated. Accordingly, the 
main purpose of this study was to expand on our previous work in which we reported 
differences in genetic-based susceptibility to MPTP in male BXD RI mice (Jones et al., 
2013). Here, we report strain differences in MPTP neurotoxicity in females and the sexes 
combined to show where they agree and where they appear to differ regarding MPTP 
neurotoxicity. Our data show a remarkable concordance between the female and male BXD 
mice for DA-based MPTP toxicity in the striatum.
2. Materials and methods
2.1. Animals
Female mice (age range from 2 to 8 months) from nine of the ten BXD strains utilized to 
evaluate MPTP neurotoxicity that we reported results in males (Jones et al., 2013) were 
used. One strain, BXD27 is a poor breeder and no female mice were available. Ten days 
prior to MPTP treatment, all of the animals were transferred from the University of 
Tennessee Health Science Center to the Centers for Disease Control, National Institute of 
Occupational Safety and Health (NIOSH) laboratory in Morgantown, West Virginia. The 
animals were maintained on a 12:12 h light and dark cycle and had free access to food and 
water. All procedures conducted on the animals were approved by the NIOSH Institutional 
Animal Care and use Committee and in accordance with the NRC guide for the Care and 
Use of Laboratory Animals (National Academy Press, 1996). NIOSH is an AAALAC 
accredited institution.
2.2. MPTP and reagents
MPTP-HCl used in the study was provided by Aldrich (Milwaukee, WI, USA). Mouse anti-
rat tyrosine hydroxylase (TH) monoclonal antibody and rabbit anti-rat TH polyclonal 
antibody were purchased from Sigma (St. Louis, MO) and Calbiochem (San Diego, CA) 
respectively. Details regarding GFAP antibodies used in the study can be found in 
O’Callaghan (2002).
2.3. MPTP treatment and brain dissection
All mice were injected s.c. with 12.5 mg/kg MPTP or saline (O’Callaghan et al., 1990). We 
have previously shown this dosing regimen to have a significant effect on the striatum as 
evidenced by a decrease in DA and its metabolites, a loss in TH protein and an increase in 
GFAP indicating an astrogliosis in response to injury. Also the regimen produces minimal to 
no damage to DA cell bodies in the substantia nigra pars compacta (SNc). All of the animals 
were decapitated forty-eight hours after injection and the striatum dissected for 
neurochemical analysis.
2.4. Biochemical assays
Following the same procedures (see Jones et al., 2013) we measured striatal monoamines by 
HPLC with electrochemical detection from the left striatum and TH and GFAP by sandwich 
ELISA in the right side (O’Callaghan, 1991, 2002; Sriram et al., 2004; O’Callaghan et al., 
Alam et al. Page 3
Neurotoxicology. Author manuscript; available in PMC 2016 October 05.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
2014). Values for the monoamines were normalized by tissue weight and the TH and GFAP 
values were normalized to total homogenate protein assayed by BCA (Smith et al., 1985).
2.5. Data analysis
Three between-subjects factors (strain, sex, treatment) analysis of variance (ANOVA) was 
used to evaluate the data (SAS Institute Cary NC). Pairwise comparisons were made using 
the Tukey HSD test with α set at 0.05. The male data used for comparisons here are from 
Jones et al. (2013). We also performed principal component analysis (PCA) on the 
difference values, saline minus MPTP, for DA, DOPAC, HVA and TH for quantitative trait 
loci (QTL) mapping of emergent eigentraits using the WebQTL software at 
www.genenetwork.org. Strain means for all data presented herein are available to anyone at 
no cost at this website.
3. Results
3.1. Effects of MPTP on DA neurochemistry in the striatum
3.1.1. Effects of MPTP on DA in the striatum—ANOVA revealed a significant main 
effect for strain with BXD32 and BXD48 having the lowest and highest DA concentrations 
respectively (Fig. 1, left panel). There were also significant main effects for treatment and 
sex. The strain × sex, treatment × strain and strain × sex × treatment interactions were also 
significant.
The percent of control (MPTP vs. saline) for DA in the striatum by sex is shown in Fig. 1, 
right panel. BXD40 showed the highest DA loss in the striatum in both sexes, BXD84 
showed the least loss in females and BXD29 the least loss in males (Fig. 1, right panel).
3.1.2. Effects of MPTP on DOPAC in the striatum—Basal levels of DOPAC differed 
among the females with BXD40 and BXD69 showing the lowest and highest DOPAC levels 
respectively (Fig. 2, left panel). For sexes combined ANOVA revealed significant main 
effects of strain, sex and treatment. Significant strain × sex and strain × treatment 
interactions were also observed. The percent of control (MPTP vs. saline) for DOPAC in the 
striatum by sex is shown in Fig. 1, right panel. BXD40 and BXD84 showed the highest and 
lowest DOPAC loss respectively in the striatum in both sexes.
3.1.3. Effects of MPTP on HVA in the striatum—ANOVA revealed significant main 
effects for strain and treatment. Significant differences in basal levels of HVA among 
females were observed with BXD9 and BXD32 having the highest and lowest HVA 
concentration respectively (Fig. 3 left panel). The main effect for sex was not significant. 
The strain × treatment interaction was significant. The Strain × sex, treatment × sex and 
strain × sex × treatment interactions were not significant. The percent of control (MPTP vs. 
saline) for HVA in the striatum in both sexes is shown in Fig. 3, right panel. Strain BXD40 
has the highest HVA loss in both sexes.
3.1.4. Effects of MPTP on DA turnover, (DOPAC/DA)—ANOVA revealed significant 
main effects for strain with BXD48 and BXD69 62 having the lowest and highest basal 
levels of DOPAC/DA in females respectively (Fig. 4, left panel). ANOVA revealed 
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significant effects for sex and treatment on DOPAC/DA. There were no significant 
differences in DOPAC/DA levels between saline and MPTP treated groups across the strains. 
DOPAC is one of two major metabolites, the other being homovanillic acid (HVA). DA 
turnover can thus be estimated by calculating the ratio of either metabolite to the amine. 
DOPAC/DA is considered to reflect presynaptic processes as DOPAC is produced by 
monoamine oxidase and HVA/DA is thought to relect postsynaptic process as it is produced 
by catechol-O-methyltransferase. Changes in these indices can indicate pharmacological 
treatments, disease-relevant damage or compensation. Here, post hoc test revealed no 
differences between saline and MPTP groups across the strains. Strain × sex interaction was 
significant. Strain × treatment, sex × treatment and strain × sex × treatment interactions were 
not significant. The percent of control (MPTP vs. saline) of striatal HVA/DA for both sexes 
is shown in Fig. 4, right panel.
3.1.5. Effects of MPTP on DA turnover (HVA/DA)—In females BXD69 and BXD9 
showed the lowest and highest basal levels for HVA/DA respectively (Fig. 5 left panel). 
ANOVA revealed significant main effects for strain, sex and treatment. The sex × strain, 
strain × treatment, treatment × sex and strain × sex × treatment interactions were also 
significant. The percent of control (MPTP vs. saline) for HVA/DA in the striatum in both 
sexes is shown in Fig. 5 (right panel). With the exception of strains 32 and 40, there was 
good consistency between the sexes.
3.2. Effects of MPTP on serotonin (5-HT) and 5-hydroxyindoleacetic acid (5-HIAA)
ANOVA revealed significant main effects for strain with BXD69 and BXD84 having the 
lowest basal levels of 5-HT and BXD48 the highest 5-HT basal level in females (data not 
presented). We observed small but significant effects by omnibus F for treatment, and sex on 
5HT; however, post hoc tests showed no differences between saline and MPTP across the 
strains. There was no significant effect of MPTP on 5-HIAA.
3.3. Effects of MPTP on tyrosine hydroxylase (TH)
ANOVA revealed significant main effects in basal level by strain with BXD29 and BXD9 
having the lowest and highest values, respectively in females (Fig. 6 left panel). We 
observed significant main effects for treatment. The main effect for sex was not significant. 
The Sex × strain, strain × treatment, sex × treatment and sex × treatment × strain interactions 
were all significant. Percent of control (MPTP-saline) for TH in both sexes is shown in the 
right panel with BXD62 showing the lowest TH loss in both sexes and BXD40 showing the 
highest loss in both sexes (Fig. 6, right panel).
3.4. Effects of MPTP on GFAP in the striatum
Fig. 7 (left panel) shows that overall, MPTP increased protein expression of the astrocyte 
marker, GFAP. ANOVA revealed significant main effects for strain with BXD48 and BXD29 
having the lowest and highest basal levels, respectively, of GFAP in females. For sexes 
combined (Fig. 7, right panel), the strain by treatment effect was significant with BXD69 
showing the greatest in males, BXD9 showing the greatest in females and BXD62 showing 
the least elevation in GFAP concentration in both sexes.
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4. Correlational analysis of MPTP effects between the sexes
We observed significant Pearson product-moment correlations between the sexes for DA, 
HVA and TH (Table 1).
5. Principal component mapping
When performing quantitative trait loci analysis (QTL) with multiple, related endpoints, 
principal components analysis can reduce the number of related variables to one or more 
principal components or eigentraits and actually increase the signal for QTL analysis. For 
this study, we combined mean difference scores across the 9 strains for DA, DOPAC, HVA 
and TH into one principal component, or eigentrait, that accounted for 70% of the variance. 
As we found earlier in males (Jones et al., 2013), the eigentrait for the females mapped to 
chromosome 1 at the same locus, about 60, Mb with a suggestive LOD (Log of Odds) score 
of about 2.6 (suggestive limit was 2.49). When the data from the sexes were combined, the 
LOD score for the QTL reached significance at 5.0.
6. Discussion
This is a follow up to our previous study (Jones et al., 2013), in which we examined the 
effect of host susceptibility to MPTP in male BXD mice. Genetic-based response variation 
was examined in females from nine of the same strains previously evaluated in males. The 
agreement in some of the outcomes but not all, between sexes was significant. The 
correlation for DA measures, except for DOPAC, were significantly high whereas DOPAC 
and GFAP were not significantly correlated between males and females suggesting possible 
sex differences in the metabolism of DA and in the astroglial response to dopaminergic 
neurotoxicity. These differences leave open the possibility for closer investigation of the role 
of sex in future studies. Because only a limited number of strains were evaluated it remains 
to be seen if studying a greater number of strains should occur before concluding that sex 
does not play a role. Also encouraging, is the significant QTL obtained for the DA aggregate 
response to MPTP. Mapping with only 9–10 strains however, is risky and nomination of 
candidate genes should await replication with more strains.
DA turnover as indicated by DOPAC/DA showed no evidence of MPTP treatment, whereas 
HVA/DA was generally increased by MPTP. While the exact mechanism for this is not 
possible to determine here, it may reflect a decrease in the efficacy of reuptake by the DA 
transporter (see below). In related work, Ookubo et al. (2009) reported sex differences in 
MPTP neurotoxicity in C57BL/6 mice. They treated the animals with 20 mg/kg MPTP every 
2 h for a total of 4 injections. Four groups were treated in this manner (vs. saline control) 
and tissues harvested at 5 h, 1, 3, and 7 days. At 5 h, there were no sex differences; however, 
beginning on day 1, females showed greater and increasing decreases than males in striatal 
DA and HVA. TH showed greater decreases in both sexes beginning at 5 h with greater loss 
in females beginning on day 1. For GFAP, females showed greater increases than males 
beginning at 5 h and continuing to day 3. Comparing to our results, at our dose, we observed 
good agreement in DA system perturbation between the sexes, but not as much for GFAP. 
For GFAP, we saw greater increases in females from three of the 9 strains, but greater 
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response in males in two strains. The C57BL/6 strain is one of two founder strains for the 
BXD recombinant inbred family, DBA/2 being the other. Neither of the parental strains was 
available to us; however, the allelic differences between the two were present in our group of 
9 RI strains. The effects that we report across the strains show continuous variation and thus 
additive genetic influence from alleles from multiple genes donated by the parental strains. 
The point is that sex differences in response to toxicants like MPTP likely depend on genetic 
constitution as well as dose and dosing conditions. What is also of interest is Ookubo et al. 
(2009) report a greater decrease in DA transporter protein in females compared to males 
after 3 days.
MPTP neurotoxicity shows wide, genetic variability with responses showing continuous 
distributions, indicating the involvement of multiple genes in determining the susceptibility 
to MPTP toxicity. In other words, host susceptibility is considered to be a polygenic or 
complex trait, involving several genes that interact with the environment and likely with 
each other. Systems genetics analysis together with a forward genetics approach (starting 
with examining phenotypes followed by identifying candidate genes) is a powerful 
technique to identify underlying mechanisms. As shown here, the combination of several 
related phenotypes through principal components analysis strengthens the ability to locate 
and nominate candidate genes.
By using systems genetics, we showed that the extent of MPP+ production was 
quantitatively unrelated to the extent of DA loss in the striatum and showing once again that 
MPTP neurotoxicity is highly complex and determined by multiple factors (Jones et al., 
2014). There is evidence showing the possible involvement of other enzymes such as 
mitochondrial cytochrome P450 2D6 (CYP2D6) in addition to monoamine oxidase B 
(MAOB) in the metabolism of MPTP to MPP+ (Bajpai et al., 2012). These researchers 
showed that the mitochondrial enzyme CYP2D6 located in the dopaminergic cells of 
substantia nigra is capable of metabolizing MPTP to MPP+, almost with the same efficiency 
as MAOB. A future examination of CYP2D6 in BXD RI strains would provide additional 
insight into the factors controlling the neurotoxic response to MPTP in these strains. The 
existence of multiple enzymes for the metabolism of MPTP to the active neurotoxic agent 
MPP+ indicates that MPTP neurotoxicity is a complex trait involving multiple pathways and 
potentially multiple genes. Examining the effect of CYP2D6 polymorphisms along with 
other factors such as DA transporter polymorphisms and genetic differences in 
mitochondrial complex I players will likely shed light on the complex pathways involved in 
MPTP toxicity.
The results of this study show the existence of a broad response variation concerning MPTP 
toxicity among different strains of female BXD RI mice which resembles individual 
differences observed in humans. Mapping these differences enables researchers to pinpoint 
polymorphisms and candidate genes that may be involved in increased risk for complex 
phenotypes such as neurotoxicity in general and also neurodegenerative diseases including 
PD.
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7. Conclusion
This study in female BXD mice is a follow up to our previous study in males of the same 
BXD strains in which we examined the neurotoxic effect of MPTP. We have shown that 
similar to males, there is a broad range of response variation in the females among BXD 
strains. Moreover, there is remarkable similarity in the neurotoxic responses to MPTP 
between the sexes. But, there are some differences and whether these differences stem from 
measurement or methodological error or represent important biological processes remains to 
be seen. This work thus sets the stage for more extensive work in many more BXD strains 
(about 100 exist) or in similar genetic reference populations. Such work will allow include 
gene mapping and gene expression resulting in the nomination and confirmation of 
candidate genes. Such studies will aid us in understanding the role of individual differences 
and genetic background in neurotoxicity and subsequent neurodegeneration.
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Fig. 1. 
Left panel Effect of MPTP on DA concentration in the striatum in 9 strains of BXD 
recombinant inbred (RI) female mice. The mice were injected with 12.5 mg/kg MPTP (vs. 
saline) and tissue collected 48 h later. DA content in the striatum was determined by HPLC, 
normalized to tissue wet weight and expressed as mean ± s.e.m. Right panel. Effect of 
MPTP in BXD mice expressed as% control, for both sexes. BXD40 showed the greatest 
MPTP-related DA loss for both sexes. ANOVA revealed a significant main effect for strain, 
sex and treatment (F8,140 = 17.21, F1,140 = 7.77, F1,140 = 849.86 respectively, p < 0.01 for 
each) and significant strain × sex, strain × treatment and strain × sex × treatment interaction 
(F8,140 = 5.49, F8,140 = 17.37 respectively, p < 0.01 for both, F8,140 = 2.2, p < 0.05 
respectively). (n = 5 per strain and treatment, b p < 0.05, showing significant differences 
between saline and MPTP treated groups).
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Fig. 2. 
Left panel Effect of MPTP on striatal DOPAC in females. Mice were injected with 12.5 
mg/kg MPTP (vs. saline) and tissue harvested 48 h later. DOPAC content in striatum was 
determined by HPLC, normalized to tissue wet weight and expressed as mean ± s.e.m. 
Right panel. The effect of MPTP on DOPAC expressed as % control for both sexes. BXD40 
showed the greatest MPTP-related DOPAC loss for both sexes. ANOVA revealed a 
significant main effect of strain, sex, treatment (F8,139 = 42.42, F1,139 = 125.81, F1,139 = 
142.24, respectively, p < 0.01 for each) and significant strain × sex interaction (F8,139 = 
24.39, p < 0.01) and strain × treatment interaction (F8,139 = 2.38, p < 0.05), (n = 5 per strain 
and treatment, b p <0.05, showing significant differences between saline and MPTP treated 
groups).
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Fig. 3. 
Left panel Effect of MPTP on homovanillic acid (HVA) concentration in the striatum in 
females. The mice were injected with12.5 mg/kg MPTP or saline and tissue harvested 48 h 
later. HVA content in striatum was determined by HPLC, normalized to tissue wet weight 
and expressed as mean ± s.e.m. Significant differences in basal levels of HVA were observed 
with strain BXD32 and BXD9 having the lowest and highest HVA concentration in females 
respectively. Right panel. The effect of MPTP on HVA expressed as % control in both 
sexes. BXD 40 showed the greatest reduction in both sexes. ANOVA revealed a significant 
main effect for strain and treatment (F8,140 = 11.49, F1,140 = 111.26 respectively, p < 0.01 
for each). ANOVA revealed a significant strain × treatment interaction (F8,140 = 6.70, p < 
0.01), (n = 5 per strain and treatment, b p < 0.05, showing significant differences between 
saline and MPTP treated groups).
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Fig. 4. 
Left panel Effect of MPTP on DA turnover as determined by the ratio of DOPAC/DA in the 
striatum in female BXD mice. Mice were injected with 12.5 mg/kg MPTP (vs. saline) and 
tissue harvested 48 h later. Experimental and control values normalized to tissue wet weight 
are expressed as mean ± s.e.m. Right panel. The effect of MPTP on DOPAC/DA expressed 
as% control for both sexes. ANOVA revealed significant main effects for strain, sex and 
treatment (F8,140 = 4.42, F1,140 = 13.11, F1,140 = 6.98 respectively, p <0.01 for each), and 
significant effect for strain × sex interaction (F8,140 = 3.62, p < 0.01). (n = 5 per strain and 
treatment, b p < 0.05, showing significant differences between saline and MPTP treated 
groups).
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Fig. 5. 
Left panel Effect of MPTP on DA turnover as determined by the ratio of HVA/DA in the 
striatum of female BXD RI mice. Female mice were injected with 12.5 mg/kg MPTP (vs. 
saline) and tissue harvested 48 h later. Experimental and control values normalized to tissue 
wet weight are expressed as mean ± s.e.m. Right panel. The effect of MPTP on HVA/DA 
expressed as % control in both sexes. ANOVA revealed significant main effects for strain, 
sex and treatment (F8,140 = 24.48, F1,140 = 8.53, F1,140 = 128.89 respectively, p <0.01 for 
each).The sex × strain, strain × treatment, and strain × sex × treatment interactions were 
significant (F8,140 = 8.99, F8,140 = 19.97, F8,140 = 5.33, p < 0.01 for each). The sex × 
treatment interaction was also significant (F1,140 = 4.64, p < 0.05), (n = 5 per strain and 
treatment, b p < 0.05, showing significant differences between saline and MPTP treated 
groups).
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Fig. 6. 
Left panel The effects of MPTP on tyrosine hydroxylase (TH) concentration in the striatum 
in females. Mice were injected with 12.5 mg/kg MPTP (vs. saline) and tissue harvested 48 h 
later. TH content was determined by sandwich ELISA according to the method of 
O’Callaghan (1991) and normalized to total protein. Data are expressed as mean ± s.e.m. 
Right panel. Effect of MPTP on TH expressed as % control in both sexes. ANOVA revealed 
significant main effect of strain and treatment (F8,141 = 19.07, F1,141 = 641.67, p < 0.01 for 
each). Sex × strain, strain × treatment and sex × treatment interactions were all significant 
(F8,141 = 5.71, F8,141 = 14.40, F1,141 = 9.85, p < 0.01 for each). The sex × treatment × strain 
interaction was also significant (F8,141 = 3.31, p < 0.05), (n = 5 per strain and treatment, a p 
< 0.05, showing significant differences between saline and MPTP treated groups).
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Fig. 7. 
Left panel Effect of MPTP on the concentration of glial fibrillary acidic protein (GFAP) in 
the striatum in females. The mice were injected with 12.5 mg/kg MPTP (vs. saline) and 
tissue harvested 48 h later. GFAP content was determined by sandwich ELISA 
(O’Callaghan, 1991; O’Callaghan et al., 2014). GFAP concentrations were normalized to 
total protein and expressed as mean ± s.e.m. Right panel. Effects of MPTP on striatal GFAP 
expressed as % control in both sexes. ANOVA revealed significant strain, sex and strain × 
treatment effects (F8,138 = 20.19, F8,138 = 10.65, respectively, p < 0.01 for each), (n = 5 per 
strain and treatment, a p < 0.05, showing significant differences between saline and MPTP 
treated groups).
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